Choline acetyltransferase activity and vesamicol binding in Rett syndrome and in rats with nucleus basalis lesions

Neuroscience

Volumn 73, Issue 1, 1996, Pages 79-84

  Wenk, G L ^a   Mobley, S L ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

acetylcholine; AMPA; lesions; rats

Indexed keywords

ACETYLCHOLINE; CARRIER PROTEIN; CHOLINE ACETYLTRANSFERASE; VESAMICOL;

ADOLESCENT; ADULT; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHILD; CHOLINERGIC NERVE CELL; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG PROTEIN BINDING; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; NERVE CELL LESION; NONHUMAN; OLIVARY NUCLEUS; PRIORITY JOURNAL; PUTAMEN; RAT; RETT SYNDROME; THALAMUS;

EID: 0029951783     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/0306-4522(96)00019-X     Document Type: Article

References (38)

1. Alfonso A., Grundahl K., Duerr J. S., Han H.-P. and Rand J. B. (1993) The Caenorhabditis elegans unc-17 gene: a putative vesicular acetylcholine transporter. Science 261, 617-619.
2. 3H]Vesamicol binding in brain: autoradiographic distribution, pharmacology, and effects of cholinergic lesions. Synapse 2, 486-493.
3. Bahr B. A. and Parsons S. M. (1992) Purification of the vesamicol receptor. Biochemistry 31, 5763-5769.
4. Barnes J. M. and Henley J. M. (1992) Molecular characteristics of excitatory amino acid receptors. Prog. Neurobiol. 39, 113-133.
5. Belichenko P. V., Oldfors A., Hagberg B. and Dahlstrom A. (1994) Rett syndrome: 3-D confocal microscopy of cortical pyramidal dendrites and afferents. Neuroreport 5, 1509-1513.
6. Brittain R. T. (1969) The neuromuscular blocking action of 2-(4-phenylpeperidino)cyclohexanol (AH 5183). Eur. J. Pharmac. 8, 93-99.
7. Bronzetti E., Caporali M. G., Felici L., Niglio T., deCarolis A. S. and Amentia F. (1993) Muscarinic cholinoceptor subtypes in the rat frontoparietal cortex after ipsilateral lesions of the nucleus basalis magnocellularis. Pharmacology 46, 301-307.
8. Cornford M. E., Philippart M., Jacobs B., Scheibel A. B. and Vinters H. V. (1994) Neuropathology of Rett syndrome: case report with neuronal and mitochondrial abnormalities in the brain. J. Child Neurol. 9, 424-431.
9. Coyle J. T., Price D. L. and DeLong M. R. (1983) Alzheimer's disease: a disorder of cortical cholinergic innervation. Science 219, 1184-1190.
10. Darchen F., Scherman D. and Henry J.-P. (1989) Reserpine binding to chromaffin granules suggests the existence of two conformations of the monoamine transporter. Biochemistry 28, 1692-1697.
11. De Micheli E., Lamour Y., Bassant M. H. and Soncrant T. T. (1993) Sustained cortical metabolic responsivity to physostigmine after nucleus basalis magnocellularis ablation in rats. Brain Res. 615, 80-86.
12. Dunnett S. B., Whishaw I. Q., Jones G. J. and Bunch S. T. (1987) Behavioral, biochemical and histochemical effects of different neurotoxic amino acids injected into nucleus basalis magnocellularis of rats. Neuroscience 20, 653-669.
13. Erickson J. D., Varoqui H., Schafer M. K.-H., Modi W., Diebler M.-F., Weihe E., Rand J., Eiden L. E., Bonner T. I. and Usdin T. B. (1994) Functional identification of a vesicular acetylcholine transporter and its expression from a "cholinergic" gene locus. J. biol. Chem. 269, 21929-21932.
14. Fonnum F. (1969) Radiochemical micro assays for the determination of choline acetyltransferase and acetylcholinesterase activities. Biochem. J. 115, 465-472.
15. Gardiner I. M., de Belleroche J., Premi B. K. and Hamilton M. H. (1987) Effect of lesion of the nucleus basalis of rat on acetylcholine release in cerebral cortex: time course of compensatory events. Brain Res. 407, 263-271.
16. Geddes J. W., Monaghan D. T. and Lott I. T. (1985) Plasticity of hippocampal circuitry in Alzheimer's disease. Science 230, 1179-1181.
17. Hagberg B., Aicardi J., Dias K. and Ramos O. A. (1983) A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls. Rett syndrome: report of 35 cases. Ann. Neurol. 14, 471-479.
18. Hagberg B. and Witt-Engerstrom I. (1986) Rett syndrome: a suggested staging system for describing impairment profile with increasing age towards adolescence. Am. J. med. Genet. 24, 47-59.
19. Jellinger K., Armstrong D., Zoghbi H. Y. and Percy A. K. (1988) Neuropathology of Rett syndrome. Acta neuropath. 76, 142-158.
20. Jellinger K. and Seitelberger F. (1986) Neuropathology of Rett syndrome. Am. J. med. Genet. 24, 259-288.
21. 3H]Vesamicol binding in human brain cholinergic deficiency disorders. Neurosci. Lett. 117, 347-352.
22. Kitt C. A., Troncoso J. C., Price D. L., Naidu S. and Moser H. W. (1990) Topological changes in substantia nigra and basal forebrain neurons in Rett syndrome. Ann. Neurol. 28, 416-417.
23. Lowry O. H., Rosenbrough N. J., Farr A. L. and Randall R. J. (1951) Protein measurement with Folin phenol reagent. J. biol. Chem. 193, 265-275.
24. Matsuishi T., Urabe F., Percy A. K., Komori H., Yamashita Y., Schultz B. S., Ohtani Y., Kuriya N. and Kato H. (1994) Abnormal carbohydrate metabolism in cerebrospinal fluid in Rett syndrome. J. Child Neurol. 9, 26-30.
25. Mesulam M.-M., Mufson E. J., Levey A. I. and Wainer B. W. (1983) Cholinergic innervation of cortex by the basal forebrain: cytochemistry and cortical connections of the septal area diagonal band nuclei, nucleus basalis (substantia innominata) and hypothalamus in the rhesus monkeys. J. comp. Neurol. 214, 170-197.
26. Pedata F., Lo Conte G., Sorbi S., Marconcini-Pepeu I. and Pepeu G. (1982) Changes in high affinity choline uptake in rat cortex following lesions of the magnocellular forebrain nuclei. Brain Res. 233, 359-367.
27. Ransmayr G., Cervera P., Hirsch E., Ruberg M., Hersh L. B., Duyckaerts C., Hauw J. J., Delumeau C. and Agid Y. (1989) Choline acetyltransferase-like immunoreactivity in the hippocampal formation of control subjects and patients with Alzheimer's disease. Neuroscience 32, 701-714.
28. Rett A. (1966) Uber ein zerebral-atrophisches syndrom bei hyperammonamie. Wein Med. Wschr. 116, 723-726.
29. Rett Syndrome Diagnostic Criteria Work Group (1988) Diagnostic criteria for Rett syndrome. Ann. Neurol. 23, 425-428.
30. 3H]vesamicol binding in the temporal cortex of patients with Alzheimer's disease, Parkinson's disease, and rats with basal forebrain lesions. Neuroscience 35, 327-333.
31. Rye D. B., Wainer B. H., Mesulam M.-M., Mufson E. J. and Saper C. B. (1984) Cortical projections arising from the basal forebrain: a study of cholinergic and noncholinergic components employing combined retrograde tracing and immunohistochemical localization of choline acetyltransferase. Neuroscience 13, 627-643.
32. Tucek S. (1990) The synthesis of acetylcholine: twenty years of progress. Prog. Brain Res. 84, 467-477.
33. Varoqui H., Diebler M.-F., Meunier F.-M., Rand J. B., Usdin T. B., Bonner T. I., Eiden L. E. and Erickson J. D. (1994) Cloning and expression of the vesamicol binding protein from the marine ray Torpedo: homology with the putative vesicular acetylcholine transporter UNC-17 from Caenorhabditis elegans. Fedn Eur. biochem. Socs 342, 97-102.
34. Wenk G. L., Harrington C. A., Tucker D. A., Rance N. E. and Walker L. C. (1992) Basal forebrain neurons and memory: a biochemical, histological and behavioral study of differential vulnerability to ibotenate and quisqualate. Behav. Neurosci. 106, 909-923.
35. Wenk G. L., O'Leary M., Nemeroff C. B., Bissette G., Moser H. and Naidu S. (1993) Neurochemical alterations in Rett syndrome. Devl Brain Res. 74, 67-72.
36. Wenk G. L., Naidu S., Casanova M. F., Kitt C. A. and Moser H. (1991) Altered neurochemical markers in Rett's syndrome. Neurology 41, 1753-1756.
37. Wenk G. L., Stoehr J. D., Mobley S. L., Gurney J. and Morris R. J. (1996) Age-related decrease in vulnerability to excitatory amino acids in the nucleus basalis. Neurobiol. Aging 17, 1-7.
38. Whitehouse P. J., Price D. L., Clark A. W., Coyle J. T. and DeLong M. R. (1981) Alzheimer disease: evidence for selective loss of cholinergic neurons in the nucleus basalis. Ann. Neurol. 10, 122-126.